<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>药事纵横 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2021-01-05T07:29:41+08:00</updated>
  <subtitle>药事纵横是一个由多位制药精英联合创办的媒体平台，旨在分享与传递药品研发、生产和注册中所涉及的技术、经验和情报，欢迎关注和投稿！投稿请发442015666@qq.com</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>体外溶出与体内不相关？试试流通池法溶出</title>
    <updated>2021-01-04T20:26:14+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-04:/s/rJ395GpVa3PggALqg5BlSA</id>
    <link href="https://mp.weixin.qq.com/s/rJ395GpVa3PggALqg5BlSA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>邀请函 | 临床开发与创新合作论坛 2021</title>
    <updated>2021-01-04T20:26:14+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-04:/s/Gqfp2nDYQ-rUnBsLRdHz6g</id>
    <link href="https://mp.weixin.qq.com/s/Gqfp2nDYQ-rUnBsLRdHz6g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>几张图了解单抗市场的变化</title>
    <updated>2021-01-04T20:26:14+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-04:/s/r6xXlvymbj41SFOhrFPUqw</id>
    <link href="https://mp.weixin.qq.com/s/r6xXlvymbj41SFOhrFPUqw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>职场中无处不在的知识垄断</title>
    <updated>2021-01-04T20:26:14+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-04:/s/fvHqyLcvdU6wl4J-klfZ9g</id>
    <link href="https://mp.weixin.qq.com/s/fvHqyLcvdU6wl4J-klfZ9g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>2020年最值得关注的“重磅炸弹”级新药</title>
    <updated>2021-01-04T11:52:16+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-04:/s/6SqIGkJRocnewEHe9qSMyQ</id>
    <link href="https://mp.weixin.qq.com/s/6SqIGkJRocnewEHe9qSMyQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>再极医药完成近2亿元人民币的C轮融资，优选资本领投</title>
    <updated>2021-01-04T11:52:16+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-04:/s/nt8PnEHe5aXjiPYYJKXoBQ</id>
    <link href="https://mp.weixin.qq.com/s/nt8PnEHe5aXjiPYYJKXoBQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>压片合格，总混含量却不合格，为什么？</title>
    <updated>2021-01-04T11:52:16+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-04:/s/JIu-5ywMll7nC9XsE9unEQ</id>
    <link href="https://mp.weixin.qq.com/s/JIu-5ywMll7nC9XsE9unEQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>年终大总结：我眼中值得提一嘴的新批改良新药</title>
    <updated>2021-01-03T14:55:59+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-03:/s/0-vPyHDbC9nNbfehZAPb0A</id>
    <link href="https://mp.weixin.qq.com/s/0-vPyHDbC9nNbfehZAPb0A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>2020年EMA和PMDA率先批准上市的18个新药逐个评述</title>
    <updated>2021-01-02T11:10:08+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-02:/s/r8vGmMBGB95UDPXr-oojdQ</id>
    <link href="https://mp.weixin.qq.com/s/r8vGmMBGB95UDPXr-oojdQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>新公众号“药海书香”，期待各位大佬的关注</title>
    <updated>2021-01-02T11:10:08+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-02:/s/oW8NyJzQOsk901kzbMxVvg</id>
    <link href="https://mp.weixin.qq.com/s/oW8NyJzQOsk901kzbMxVvg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>创新药年终总结：2020年NMPA批准的13个1类新药逐个评述</title>
    <updated>2021-01-01T11:34:27+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-01:/s/sOdplmTnSVgrVDxZqkcd-g</id>
    <link href="https://mp.weixin.qq.com/s/sOdplmTnSVgrVDxZqkcd-g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>FDA批准药物的全景分析（二）：复杂制剂及制剂未来</title>
    <updated>2020-12-31T05:55:51+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-31:/s/J0EhjNacmqNwfq0iS0opRA</id>
    <link href="https://mp.weixin.qq.com/s/J0EhjNacmqNwfq0iS0opRA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>NMPA批准和记黄埔的索凡替尼用于神经内分泌瘤治疗</title>
    <updated>2020-12-31T05:55:51+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-31:/s/Mu356o9k4faGSxss_20iwA</id>
    <link href="https://mp.weixin.qq.com/s/Mu356o9k4faGSxss_20iwA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>医药三大局势已定，不知道的白混了~</title>
    <updated>2020-12-31T05:55:51+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-31:/s/9HGKbltxYK9_ueSPmD2p_A</id>
    <link href="https://mp.weixin.qq.com/s/9HGKbltxYK9_ueSPmD2p_A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>2020医保谈判，哪些抗肿瘤药纳入医保？（附名单）</title>
    <updated>2020-12-31T05:55:51+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-31:/s/09_V2CsALWrxqHL-sJjVGA</id>
    <link href="https://mp.weixin.qq.com/s/09_V2CsALWrxqHL-sJjVGA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>FDA批准药物的全景分析：药物概况、给药途径和剂型分布（一）</title>
    <updated>2020-12-29T19:57:43+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-29:/s/RLAHelxlfZzTsab3oYAmig</id>
    <link href="https://mp.weixin.qq.com/s/RLAHelxlfZzTsab3oYAmig" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>创新药的盛宴（医保谈判结果简评，附谈判降幅排名）</title>
    <updated>2020-12-29T19:57:43+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-29:/s/wDTMDjc538bYabSFwSM_ng</id>
    <link href="https://mp.weixin.qq.com/s/wDTMDjc538bYabSFwSM_ng" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>杂质检测方法精密度与耐用性验证是否需要加标？</title>
    <updated>2020-12-29T19:57:43+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-29:/s/AZVkx_NfBznqifoq9OZrOw</id>
    <link href="https://mp.weixin.qq.com/s/AZVkx_NfBznqifoq9OZrOw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>三医联动新消息：事关精神心理疾病的医疗保障、药品“带量采购”</title>
    <updated>2020-12-28T20:19:12+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-28:/s/JBYFi6mizqYnPav3NP2KUQ</id>
    <link href="https://mp.weixin.qq.com/s/JBYFi6mizqYnPav3NP2KUQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>韩国特应性皮炎新药寻求中国合作伙伴</title>
    <updated>2020-12-28T20:19:12+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-28:/s/fVWesQ52wRryK9ySX_d4qA</id>
    <link href="https://mp.weixin.qq.com/s/fVWesQ52wRryK9ySX_d4qA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>